Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study
J. An, X. Li, et al.
Prognosis Individualized: Survival predictions for WHO grade II and III gliomas with a machine learning-based web application
M. Karabacak, P. Jagtiani, et al.
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
S. Mukherjee, C. N. Hurt, et al.
Immuno-histologic and histomorphometric evaluation of *Angelica sinensis* adjunctive to β-tricalcium phosphate in critical-sized class II furcation defects in dogs
D. W. Eldeeb, A. M. Hommos, et al.
